Spectrum and functional validation of PSMB5 mutations in multiple myeloma
Despite an increasing number of approved therapies, multiple myeloma (MM) remains an incurable disease and only a small number of patients achieve prolonged disease control. Some genes have been linked with response to commonly used anti-MM compounds, including immunomodulators (IMiDs) and proteasom...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
Leukemia
Year: 2018, Volume: 33, Issue: 2, Pages: 447-456 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-018-0216-8 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1038/s41375-018-0216-8 Verlag: https://www.nature.com/articles/s41375-018-0216-8 
|
| Author Notes: | Santiago Barrio, Thorsten Stühmer, Matteo Da-Viá, Clara Barrio-Garcia, Nicola Lehners, Andrej Besse, Isabel Cuenca, Andoni Garitano-Trojaola, Severin Fink, Ellen Leich, Manik Chatterjee, Christoph Driessen, Joaquin Martinez-Lopez, Andreas Rosenwald, Roland Beckmann, Ralf C. Bargou, Esteban Braggio, A. Keith Stewart, Marc S. Raab, Hermann Einsele, K. Martin Kortüm |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1677982187 | ||
| 003 | DE-627 | ||
| 005 | 20230428021912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191001r20192018xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-018-0216-8 |2 doi | |
| 035 | |a (DE-627)1677982187 | ||
| 035 | |a (DE-599)KXP1677982187 | ||
| 035 | |a (OCoLC)1341244793 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Barrio, Santiago |e VerfasserIn |0 (DE-588)119997160X |0 (DE-627)1682116190 |4 aut | |
| 245 | 1 | 0 | |a Spectrum and functional validation of PSMB5 mutations in multiple myeloma |c Santiago Barrio, Thorsten Stühmer, Matteo Da-Viá, Clara Barrio-Garcia, Nicola Lehners, Andrej Besse, Isabel Cuenca, Andoni Garitano-Trojaola, Severin Fink, Ellen Leich, Manik Chatterjee, Christoph Driessen, Joaquin Martinez-Lopez, Andreas Rosenwald, Roland Beckmann, Ralf C. Bargou, Esteban Braggio, A. Keith Stewart, Marc S. Raab, Hermann Einsele, K. Martin Kortüm |
| 264 | 1 | |c 2019 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 19 July 2018 | ||
| 500 | |a Gesehen am 19.11.2019 | ||
| 520 | |a Despite an increasing number of approved therapies, multiple myeloma (MM) remains an incurable disease and only a small number of patients achieve prolonged disease control. Some genes have been linked with response to commonly used anti-MM compounds, including immunomodulators (IMiDs) and proteasome inhibitors (PIs). In this manuscript, we demonstrate an increased incidence of acquired proteasomal subunit mutations in relapsed MM compared to newly diagnosed disease, underpinning a potential role of point mutations in the clonal evolution of MM. Furthermore, we are first to present and functionally characterize four somatic PSMB5 mutations from primary MM cells identified in a patient under prolonged proteasome inhibition, with three of them affecting the PI-binding pocket S1. We confirm resistance induction through missense mutations not only to Bortezomib, but also, in variable extent, to the next-generation PIs Carfilzomib and Ixazomib. In addition, a negative impact on the proteasome activity is assessed, providing a potential explanation for later therapy-induced eradication of the affected tumor subclones in this patient. | ||
| 534 | |c 2018 | ||
| 700 | 1 | |a Giesen, Nicola |d 1983- |e VerfasserIn |0 (DE-588)141844272 |0 (DE-627)631828524 |0 (DE-576)32643657X |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 33(2019), 2, Seite 447-456 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Spectrum and functional validation of PSMB5 mutations in multiple myeloma |
| 773 | 1 | 8 | |g volume:33 |g year:2019 |g number:2 |g pages:447-456 |g extent:10 |a Spectrum and functional validation of PSMB5 mutations in multiple myeloma |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41375-018-0216-8 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41375-018-0216-8 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191001 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 19 | ||
| 998 | |g 141844272 |a Giesen, Nicola |m 141844272:Giesen, Nicola |d 910000 |d 910100 |e 910000PG141844272 |e 910100PG141844272 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 999 | |a KXP-PPN1677982187 |e 3519213532 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"person":[{"role":"aut","family":"Barrio","display":"Barrio, Santiago","given":"Santiago"},{"role":"aut","given":"Nicola","display":"Giesen, Nicola","family":"Giesen"},{"role":"aut","display":"Raab, Marc-Steffen","family":"Raab","given":"Marc-Steffen"}],"physDesc":[{"extent":"10 S."}],"name":{"displayForm":["Santiago Barrio, Thorsten Stühmer, Matteo Da-Viá, Clara Barrio-Garcia, Nicola Lehners, Andrej Besse, Isabel Cuenca, Andoni Garitano-Trojaola, Severin Fink, Ellen Leich, Manik Chatterjee, Christoph Driessen, Joaquin Martinez-Lopez, Andreas Rosenwald, Roland Beckmann, Ralf C. Bargou, Esteban Braggio, A. Keith Stewart, Marc S. Raab, Hermann Einsele, K. Martin Kortüm"]},"title":[{"title":"Spectrum and functional validation of PSMB5 mutations in multiple myeloma","title_sort":"Spectrum and functional validation of PSMB5 mutations in multiple myeloma"}],"relHost":[{"note":["Gesehen am 15.03.04"],"id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"part":{"extent":"10","year":"2019","issue":"2","pages":"447-456","volume":"33","text":"33(2019), 2, Seite 447-456"},"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"32046699X","title":[{"title":"Leukemia","title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal"}],"pubHistory":["Nachgewiesen 11.1997 -"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Spectrum and functional validation of PSMB5 mutations in multiple myelomaLeukemia","origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997"}]}],"recId":"1677982187","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1677982187"],"doi":["10.1038/s41375-018-0216-8"]},"note":["Published online: 19 July 2018","Gesehen am 19.11.2019"]} | ||
| SRT | |a BARRIOSANTSPECTRUMAN2019 | ||